GeneDx Holdings Corp.
WGS
$85.74
-$5.87-6.41%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -38.58M | -52.29M | -83.50M | -117.47M | -135.02M |
| Total Depreciation and Amortization | 21.48M | 21.05M | 15.89M | 18.63M | 23.75M |
| Total Amortization of Deferred Charges | -- | -- | 2.60M | 2.60M | 2.60M |
| Total Other Non-Cash Items | 28.90M | 27.48M | 35.19M | 38.53M | 8.46M |
| Change in Net Operating Assets | -13.71M | -24.75M | -25.35M | -34.29M | -40.79M |
| Cash from Operations | -1.90M | -28.50M | -55.17M | -92.00M | -141.00M |
| Capital Expenditure | -11.18M | -5.49M | -4.82M | -4.28M | -5.69M |
| Sale of Property, Plant, and Equipment | -- | -- | 147.00K | 400.00K | 4.03M |
| Cash Acquisitions | -- | -- | 0.00 | 0.00 | -12.14M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -29.21M | -24.64M | -29.81M | -49.97M | -28.62M |
| Cash from Investing | -40.38M | -30.13M | -34.48M | -53.85M | -42.42M |
| Total Debt Issued | -- | -- | 48.55M | 48.55M | 48.55M |
| Total Debt Repaid | -3.67M | -3.23M | -3.16M | -3.37M | -3.01M |
| Issuance of Common Stock | 61.99M | 47.39M | 14.86M | 180.00K | 7.61M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 58.32M | 44.16M | 60.24M | 45.36M | 53.14M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 16.03M | -14.47M | -29.41M | -100.49M | -130.28M |